Delivery Order SPE2DB20D7059-SPE2DB25FPZZ6

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566450993 - ALBUTEROL HFA 90 MCG INHALER 8.5GM. The fixed-price delivery order, valued at $2,404.29, has a period of performance through November 18, 2024. The contract was an unrestricted award, not designated under any set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,091.64 firm fixed-price delivery order is for the supply of 4562879737 - ALBUTEROL HFA 90 MCG INHALER 8.5GM. The contract has an ultimate completion date of November 22, 2023 and was awarded on November 21, 2023. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,441.05 firm fixed-price delivery order is for the supply of 4566265065 - Albuterol HFA 90 MCG Inhaler 18GM. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.04 firm-fixed-price delivery order covers the procurement of 4566208960 units of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical respiratory medication, with an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,041.47 firm fixed-price delivery order is for the procurement of 4,566,437,175 units of Albuterol HFA 90 MCG Inhaler, 8.5GM, with a completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.00 Firm Fixed Price Delivery Order is for the procurement of 4558866863 - Albuterol HFA 90 MCG Inhaler 18GM. The contract has an ultimate completion date of October 25, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF0Q5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563117677 ALBUTEROL HFA 90 MCG INHALER 8.5GM, with a ceiling value of $1,516.55 and a completion date of December 18, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,399.78 firm-fixed price delivery order is for the supply of Albuterol HFA 90 MCG inhalers, with an ultimate completion date of October 21, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYH7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,013.45 delivery order is for the supply of 4562252730 - ALBUTEROL HFA 90 MCG INHALER 8.5GM to support military healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,109.58 firm fixed-price delivery order covers the procurement of Albuterol HFA 90 MCG inhalers with an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FPZZ6
    Delivery Order

This federal contract award, with ID SPE2DB20D7059|SPE2DB25FPZZ6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,046.88 firm fixed-price delivery order is for the procurement of 4567271781 - ALBUTEROL HFA 90 MCG INHALER 8.5GM, with a performance period running through February 18, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/16/25, 12:05 PM